|
WO2021073494A1
|
|
The salts of a compound and the crystalline forms thereof
|
|
WO2020244637A1
|
|
Tricyclic compounds and their use
|
|
WO2020228823A1
|
|
Novel amide compounds and uses thereof
|
|
CN111184698A
|
|
Fuquintinib preparation and application thereof
|
|
CN110407837A
|
|
The salt of compound, its crystal form and its application
|
|
CN110386937A
|
|
The crystal form of compound and unformed
|
|
CN108178748A
|
|
The synthetic method of 4,6- dichloro pyrimidine -5- formonitrile HCNs
|
|
TW201833112A
|
|
Crystalline form of a compound
|
|
CN109694355A
|
|
The synthetic method of N- (3- alkynyl phenyl) -4,6- diamino quinazolines compounds and related intermediate
|
|
CN109694370A
|
|
The synthetic method of N- (3- alkynyl phenyl) -4,6- diamino quinazolines compounds and related intermediate
|
|
CN109694356A
|
|
The synthetic method of N- (3- alkynyl phenyl) -4,6- diamino quinazolines compounds and related intermediate
|
|
CN109467538A
|
|
The heteroaryl cyclics and application thereof that cycloolefin replaces
|
|
CN109422741A
|
|
The salt and its crystal form of compound
|
|
CN108863951A
|
|
The salt and its crystal form of compound
|
|
CN109963847A
|
|
The method for treating solid tumor
|
|
TW201639845A
|
|
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
WO2016187767A1
|
|
Pharmaceutical compositions and use thereof
|
|
CN105503877A
|
|
Imidazopyridazine compound and application thereof
|
|
CN105461702A
|
|
6-(6,7-dimethoxyquinazolin-4-yloxy)-N,2-dimethylbenzofuran-3-carboxamide crystal form
|
|
CN104812753A
|
|
Substituted pyridopyrazines as syk inhibitors
|
